Skip to content

Regenxbio RGNX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$90.05M-1,580%-$67.15M-31.2%-$61.94M-3.9%-$70.87M-33.7%$6.08M+110%
$3.86M-2.5%$3.87M-3.8%$3.89M-1.9%$3.91M-3.6%$3.96M-5.4%
$8.62M+0.9%$8.38M-12.2%$9M-9.0%$8.65M-8.3%$8.54M-11.1%
-$76.19M-327%-$52.29M-65.3%-$55.96M-38.0%-$49.34M-8.5%$33.63M+161%
$1.24M+20.6%$508K-52.9%$491K+50.6%$391K-17.5%$1.02M+83.8%
$70.59M+57.8%-$140.44M$44.74M+239%
-$13.64M-135%$139.23M-$5.79M-105%
-$19.24M-127%-$24.34M-2,777%$72.58M-7.5%
-$77.42M-337%-$52.8M-61.4%-$56.45M-38.1%-$49.73M-8.2%$32.61M+158%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Regenxbio generate?
Regenxbio (RGNX) generated -$233.8M in operating cash flow over the trailing twelve months.
What is Regenxbio's free cash flow?
After $2.6M of capital expenditures, Regenxbio's free cash flow was -$236.4M over the trailing twelve months, down 171.9% year over year.
Where does Regenxbio's cash flow data come from?
Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.